Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Zoccarato 2011 J Bioenerg Biomembr

From Bioblast
Revision as of 09:46, 3 April 2022 by Komlodi Timea (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Publications in the MiPMap
Zoccarato F, Miotto C, Cavallini L, Alexandre A (2011) The control of mitochondrial succinate-dependent H2O2 production. J Bioenerg Biomembr 43:359-66.

» PMID: 21735176 Open Access

Zoccarato F, Miotto C, Cavallini L, Alexandre A (2011) J Bioenerg Biomembr

Abstract: In brain mitochondria succinate activates H(2)O(2) release, concentration dependently (starting at 15 μM), and in the presence of NAD dependent substrates (glutamate, pyruvate, β-hydroxybutyrate). We report that TCA cycle metabolites (citrate, isocitrate, α-ketoglutarate, fumarate, malate) individually and quickly inhibit H(2)O(2) release. When they are present together at physiological concentration (0.2, 0.01, 0.15, 0.12, 0.2 mM respectively) they decrease H(2)O(2) production by over 60% at 0.1-0.2 mM succinate. The degree of inhibition depends on the concentration of each metabolite. Acetoacetate is a strong inhibitor of H(2)O(2) release, starting at 10 μM and acting quickly. It potentiates the inhibition induced by TCA cycle metabolites. The action of acetoacetate is partially removed by β-hydroxybutyrate. Removal is minimal at 0.1 mM acetoacetate, and is higher at 0.5 mM acetoacetate. We conclude that several inhibitors of H(2)O(2) release act jointly and concentration dependently to rapidly set the required level of H(2)O(2) generation at each succinate concentration.

Cited by

  • Komlódi et al (2022) The protonmotive force - not merely membrane potential. MitoFit Preprints 2022 (in prep)

Labels:






MitoFit 2022 pmF